Similarly, P53 binds to the promoter of SCD1 and inhibits its transcription, thereby mediating lipid metabolism reprogramming and developing resistance tyrosine kinase inhibitor (TKI) induced ferritic anemia in HCC. This evidence concerns the gene TP53 and hepatocellular carcinoma.